Abstract:Alopecia areata (AA) is a condition in which hair is lost in small regions or over the entire body. It has a prevalence of 1 in 1000 and has a great impact on psychological wellbeing. AA is generally considered an autoimmune disease in which a collapse of the immune privilege system of the hair follicle has shown to play an important role, potentially driven by interferon gamma (IFN-γ). The most prominent cells located in or around the hair follicle in AA are Langerhans cells, CD4 + or CD8 + T cells, macrophages and mast cells. Langerhans cells, specialized dendritic cells, are resident in the epidermis and are known to associate with hair follicles. Therefore, we aimed to develop in vitro generated Langerhans cells contributing as an in vitro model of disease. In vitro models provide insight into the behaviour of cells and are a valuable tool before being in need of an animal model or patient samples. For this, Langerhans-like cells were generated from CD14 + monocytes in the presence of GM-CSF and TGF-β. After 10 days of cell culture, Langerhans-like cells express CD207 and CD1a but lack CD209 expression as well as Birbeck granules. Next, Langerhans-like cells were exposed to inflammatory conditions and the effect of different AA treatments was investigated. All treatments—diphencyprone contact immunotherapy, UV-B light therapy and JAK-STAT inhibition—affect the expression of costimulatory and skin-homing markers on Langerhans-like cells. Importantly, also the T cell stimulatory capacity of Langerhans-like cells was significantly reduced following treatment under inflammatory conditions. Noteworthy, JAK-STAT inhibition outperformed conventional AA treatments. In conclusion, our findings demonstrate that in vitro generated Langerhans-like cells can be used as a model of disease. Moreover, JAK-STAT inhibition may become a valuable new approach for the treatment of AA.

Induction of alopecia areata in C3H/HeJ mice using cryopreserved lymphocytes

Induction of alopecia areata in C3H/HeJ mice using polyinosinic-polycytidylic acid (poly[I:C]) and interferon-gamma

Myeloid Adherent Cells Are Involved in Hair Loss in the Alopecia Areata Mouse Model

JAK Inhibitors for the Treatment of Alopecia Areata

Pathogenesis of Alopecia Areata in C3H/He J Mice and DEBR Rats

Dermal lymphatic dilation in a mouse model of alopecia areata

Current Protocols: Alopecia Areata Mouse Models for Drug Efficacy and Mechanism Studies

Development of an improved animal model of experimental autoimmune myositis.

Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model

Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing

A mouse model of irradiation and spleen-thymus lymphocyte infusion induced aplastic anemia

CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata

487 Induction of T Cell Exhaustion by JAK1/3 Inhibition in the Treatment of Alopecia Areata

Selective Expansion of Tregs Using the IL-2 Cytokine Antibody Complex Does Not Reverse Established Alopecia Areata in C3H/HeJ Mice

Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inflammation around the hair follicle

AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice

Effects of the Lexington LaserComb on hair regrowth in the C3H/HeJ mouse model of alopecia areata

Impaired autophagy promotes hair loss in the C3H/HeJ mouse model of alopecia areata

Visual and Molecular Evidence from a Mouse Model

Treatment of in vitro generated Langerhans cells with JAK-STAT inhibitor reduces their inflammatory potential

Fibroblast cell-based therapy prevents induction of alopecia areata in an experimental model